• Financial Times: Get vaccine new variant ready

    8 days ago - By Green Light Biosciences

    GreenLight Biosciences explain to the Financial Times how messenger RNA can help get the Covid-19 vaccine new variant ready.
    GreenLight Biosciences spoke to the Financial Times about making sure that any vaccine is new variant ready for Covid-19. An extract from the article is below:
    Andrey Zarur, chief executive of Greenlight Biosciences, a biotech company that is making a messenger RNA vaccine, said it made sense to design new vaccines to “prepare for further drift”. “Then you have a better chance of your new vaccine continuing to protect against new variants,” Mr Zarur said.
    Read the...
    Read more ...